How Does Cigna Company Work?

How is Cigna reshaping healthcare delivery?

The Cigna Group entered 2025 as a dominant force with consolidated revenues above $250,000,000,000, serving over 190,000,000 customer relationships worldwide and shifting from insurer to integrated health services leader.

Cigna blends traditional insurance with a health services platform—PBM, care management, and employer solutions—to stabilize margins amid regulatory change and drive value-based care adoption. See Cigna Porter's Five Forces Analysis.

Cigna’s core operations center on two segments: Evernorth Health Services, a high-growth pharmacy and analytics platform serving third parties and insurance members, and Cigna Healthcare, the insurer focused on employer and individual medical, dental, behavioral health, and vision plans. Together they drive cost reductions by integrating pharmacy and medical data and negotiating provider and drug discounts.

Evernorth: PBM and Specialty

Evernorth includes Express Scripts and Accredo, managing prescription benefits and specialty therapies for Cigna members and third-party clients. It leverages scale to negotiate drug price concessions and capture administrative margins.

Third-Party Client Reach

Evernorth serves competing health plans, large self-insured employers, and government accounts, expanding revenue beyond insurance premiums and diversifying the Cigna business model.

Cigna Healthcare: Network-Based Insurance

Cigna Healthcare contracts with hundreds of thousands of physicians and hospitals to provide discounted care to members, focusing on U.S. Employer and Individual markets after the 2025 Medicare Advantage divestiture. Network scale underpins negotiated provider rates.

Integrated Data and Care Management

By integrating medical and pharmacy data, Cigna uses predictive analytics and care coordination to identify high-risk patients and reduce avoidable hospitalizations, lowering total cost of care for employer clients.

As of 2025 Cigna reported Evernorth serving millions of pharmacy members and negotiating savings that reduced drug costs for clients by double-digit percentages in some categories; the insurer side maintains risk pools across employer and individual markets while focusing on utilization management and provider relations.

Operational Strengths and Client Benefits

Cigna company operations combine scale, clinical programs, and technology to deliver measurable savings and improved outcomes for employers and members.

• Pharmacy benefit management process: centralized formulary negotiation and claims adjudication via Evernorth.
• Care coordination: targeted interventions for high-risk members using integrated data.
• Provider network: contractual discounts across a broad physician and hospital network.
• Revenue diversification: fee-for-service PBM and specialty pharmacy contracts with third parties.

For more on Cigna’s market positioning and customer segments see Target Market of Cigna

Complete Cigna Strategy Bundle

• 6 Full Frameworks, 1 Company – All Pre-Researched
• Each Framework Fully Sourced with Real Company Data
• Built for Strategy Courses, Case Studies & MBA Programs
• Adapt to Your Assignment – No Starting from Scratch
• 6 Frameworks: SWOT, PESTLE, Porter's, BMC, BCG and 4P's

GET FULL BUNDLE

The Cigna Group’s revenue architecture in 2025 is dominated by pharmacy services and insurance premiums, supplemented by fee-based offerings that stabilize cash flow and reduce exposure to medical cost inflation.

Pharmacy Services

Pharmacy services generated approximately 72 percent of total revenue in 2025, driven by prescription sales and administrative claims fees.

Specialty Pharmacy

Specialty pharmacy—high-cost biologics and gene therapies—delivers higher margins via specialized handling, clinical support, and patient management programs.

Insurance Premiums

Premiums accounted for about 20 percent of revenue in 2025; profitability depends on maintaining a medical care ratio target range of 81–83 percent.

Fee-Based Services

Fees from health management, data analytics subscriptions, and administrative services only agreements provide steady, low-volatility income less sensitive to medical inflation.

Claims Processing & Administrative Fees

Administrative fees for claims adjudication and pharmacy benefit management form a core monetization mechanism within the Cigna insurance structure and services explained.

Clinical Programs & Value-Based Care

Care coordination, chronic-disease management, and value-based contracts reduce total cost of care and support margin preservation across payer and provider arrangements.

The Cigna business model blends high-volume pharmacy benefit management with insured risk-bearing plans and predictable fee-for-service contracts to diversify revenue and manage earnings volatility.

Revenue Drivers & Investor Implications

Key drivers include specialty drug growth, premium mix, and scaling of fee-based offerings; investors often value the business for its 72 percent pharmacy concentration and recurring fee revenues.

• Specialty drugs: outsized impact on revenue per script and margins
• Medical care ratio: target 81–83% to protect underwriting profit
• Fee-based services: lower sensitivity to medical cost inflation
• PBM scale: leverages negotiating power with manufacturers and pharmacies

For context on corporate purpose and strategic alignment with these monetization choices, see Mission, Vision & Core Values of Cigna

From PESTLE Factors to Full Strategy Bundle

• PESTLE + SWOT + Porter's + BCG + BMC + 4P's in One Bundle
• Every Strategic Angle Covered – Nothing Left to Research
• Pre-filled with Company-Specific Research
• No Missing Sections for Your Case Study
• One Download Covers Your Entire Company Analysis

GET COMPLETE BUNDLE

Cigna’s recent strategic reshaping centers on divesting government-facing Medicare assets, accelerating share buybacks, and doubling down on pharmacy and commercial insurance capabilities to sharpen its competitive edge.

Major divestiture

In 2025 Cigna completed the sale of its Medicare Advantage and Part D businesses to Health Care Service Corporation for $3.7 billion, exiting a volatile, highly regulated government market.

Capital redeployment

Cigna redeployed capital into core commercial insurance and specialty pharmacy operations and returned capital to shareholders with over $10 billion in share repurchases between 2024 and 2025.

PBM ownership

Ownership of Express Scripts positions Cigna among the largest pharmacy benefit managers, giving scale advantages in drug pricing, utilization data, and formularies.

Specialty pharmacy strength

Accredo leads distribution for GLP-1 and orphan drugs, capturing high-growth pharmacy segments and value across negotiation, fulfillment, and patient support.

These moves reinforce Cigna company operations by concentrating on areas where its integrated model—commercial insurance plus pharmacy benefit management—delivers higher margins and defensible data-driven scale.

Competitive advantages and strategic outcomes

Cigna’s business model leverages vertical integration, proprietary utilization data, and specialty distribution to sustain margins and growth amid industry consolidation.

• Vertical integration: control from manufacturer negotiation to patient delivery through Express Scripts and Accredo
• Data moat: proprietary drug utilization and pricing insights reduce competitor parity
• Capital strategy: > $10 billion in buybacks (2024–2025) and targeted reinvestment after the $3.7 billion Medicare divestiture
• Focus on high-growth categories: GLP-1s and orphan drugs driving specialty pharmacy revenue growth

For deeper competitive context see Competitors Landscape of Cigna, which situates Cigna’s strategic moves within broader insurer and PBM market dynamics.

Cigna Business Model + Strategy Bundle

• Ideal for Essays, Case Studies & Slides
• Get BCG, SWOT, PESTLE, Porter's, 4P's Mix & BMC Together
• Company-Specific Content Already Organized
• One Bundle Replaces Days of Independent Research
• Buy the Bundle Once. Use Across All Your Assignments

GET COMPLETE ANALYSIS

The Cigna Group holds a leading role in U.S. healthcare, second to UnitedHealth Group by diversified scale, yet faces regulatory and competitive pressures that could reshape its margins and market strategy.

Industry Position

Cigna company operations span commercial insurance, employer health services, and a major pharmacy benefit management (PBM) arm, Evernorth, positioning it as a vertically integrated healthcare operator.

Competitive Landscape

Primary rivals include CVS Health and UnitedHealth Group; emerging disruptors such as Amazon Pharmacy increase pricing and delivery pressure on traditional PBM and insurer models.

Regulatory Risks

Heightened FTC and state scrutiny of PBM practices threatens rebate models and margin capture, potentially requiring structural change to how Evernorth earns fees.

Financial Targets

Cigna targets long-term annual earnings growth of 10 to 13 percent and favors a capital-light, fee-based mix driven by high-margin services like specialty drug management.

Strategic emphasis on EncircleRx, digital health, and behavioral wellness aims to capture the rising specialty drug spend—projected to reach 60 percent of drug dollars by 2026—and to shift Cigna toward fee-based services and logistics-driven value.

Risks and Strategic Responses

Regulatory, competitive, and clinical-cost risks require diversified revenue, PBM transparency, and technology-led care orchestration to protect margins and growth.

• Regulatory: FTC and state rules could ban certain rebate practices, impacting Evernorth margins and Cigna insurance structure.
• Competition: CVS and new entrants like Amazon Pharmacy intensify price and distribution challenges to Cigna services explained.
• Cost drivers: Specialty pharmaceuticals concentration increases exposure; managing utilization is critical to meet earnings targets.
• Strategic pivot: Expanding EncircleRx and digital platforms supports a shift from Medicare reliance to employer-focused, data-driven services.

For corporate history and context on Cigna company overview, see Brief History of Cigna

From Five Forces to Full Company Analysis

• Includes SWOT, PESTLE, BMC, BCG and 4P's
• Pre-Researched with Company-Specific Data
• Best Value for a Complete Analysis
• Ready to Adapt for Your Case Study
• Ready for Essays and Slidesd

GET FULL BUNDLE